SCOTT JOHN K JR. received a stock award from NAVIDEA BIOPHARMACEUTICALS, INC.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 9/1/2022ACC: 0001437749-22-021740
10% Owner
Since Sep 2018
+5.56K
Net shares
Net buyer
$0.00
Total acquired
0
Open market trades
0B · 0S
4
Total transactions
7.30K acquired · 1.74K disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
+2.50K
Price / share
—
Trade value
—
% of position
0.0%
8/31/2022
8.10M→8.10M
Total
Net shares
+2.50K
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 8/31/2022 | A · Award | +2.50K | — | — | 0.0% | 8.10M | 8.10M |
| Total | +2.50K | $0.00 | ||||||
Derivative Transactions3
Series F Redeemable Convertible Preferred Stock
Direct
Converts to
Common Stock
2.17M shares
Shares
−1.74K
Strike price
0.80
Held after
0.00
Exercisable
—
8/30/2022
Series I Convertible Preferred Stock
Direct
Converts to
Common Stock
5.33M shares
Shares
+2.40K
Strike price
0.45
Held after
2.40K
Exercisable
—
8/30/2022
Warrant to Purchase Common Stock
Direct
Converts to
Common Stock
5.33M shares
Shares
+2.40K
Strike price
0.50
Held after
2.40K
Exercisable
—
8/30/2022
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Series F Redeemable Convertible Preferred Stock Direct | Common Stock2.17M shares | 8/30/2022 | S · Sale | −1.74K | 0.80 | — | 0.00 |
| Series I Convertible Preferred Stock Direct | Common Stock5.33M shares | 8/30/2022 | P · Purchase | +2.40K | 0.45 | — | 2.40K |
| Warrant to Purchase Common Stock Direct | Common Stock5.33M shares | 8/30/2022 | P · Purchase | +2.40K | 0.50 | — | 2.40K |
Non-Derivative Holdings (Post-Transaction)2
Common Stock
IndirectShares owned10.14K
Series G Redeemable Preferred Stock
DirectShares owned3.26K
Total
3.26K direct·10.14K indirect13.40K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 10.14K | Indirect |
| Series G Redeemable Preferred Stock | 3.26K | Direct |
| Total | 13.40K | 3.26K direct·10.14K indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported